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Children with autoimmune chronic active hepatitiscan be separated into twogroups
depending on the presence in their serum of either anti-smooth muscle antibody
(SMA) or anti-liver-kidney microsome antibody (LKMA) (1). LKMA-positive au-
toimmune chronic active hepatitis may be detected early in life, present different
clinical patterns, andis frequently associated with extrahepatic autoimmune manifesta-
tions (2). The antigen recognized by LKMA has been identified as a protein with
an ,M, of 50 kD, present in a higher concentration in smooth than in rough micro-
somes. This 50-kD protein is an integral membrane protein exposed on the cyto-
plasmic side of the microsomal membrane (3). These properties are typical of the
cytochromes, a family of hemeprotein monooxygenase isozymes present in large
amounts in hepatocytes. It was recently shown that LKMA crossreacts with two
methylcholantrene-inducible isozymes ofcytochrome P450 on dot-blot analysis, sug-
gesting that the antigene, present in noninduced microsomes, has some common
epitopes with these P450 isozymes and could be a constitutive form of cytochrome
P450 (4). Here, we show that LKMA recognizes cytochrome P450 forms from the
III) subfamily.
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Affinity Purification ofHuman Anti-504D Antibodies.
￿
Sera were obtained from threechildren
with autoimmune hepatitis with high titers of LKMA in immunofluorescence (>1:100,000)
and anti-50 kD on immunoblot analysis (>1 :1,000). Rat liver microsomes were prepared
as described previously (5), and resuspended in PBS at a final protein concentration of 3
mg/ml. Microsomes were solubilized as described by Bar-Nun et al. (6) with sodium deoxy-
cholate0.4%, during 30 min, at 0°C. Aftercentrifugation at 100,000g(Ti70rotor; Beckman
Instruments, Inc., Palo Alto, CA) during 2 h at 4°C, proteins from the supernatant were
coupled to Afft-Gel 10 (Bio-Rad Laboratories, Richmond, CA) following the protocol from
the manufacturer. Solubilized microsomal proteins bound to Affi-Gel 10 were poured into
a column and used for purification of anti-50-kD antibodies from LKMA-positive human
sera, as described(7). Fractionseluted from the column were lyophilized and dialyzed. Their
specificity for the 50-kD protein was checked by immunoblot analysis against total rat liver
microsomal proteins. The same technique wasused for titration of the antibody solution be-
fore use for the screening of the rat liver cDNA library.
Screening ofRat Liver cDNA Library.
￿
Arat livercDNA library (Normalfemale adultSprague-
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Dawley) in phage XGT11 (Clontech, Palo Alto, CA) was screened as described by Young and
Davis (8). Approximately 4 x 105 recombinant phages were plated on lawns of Escherichia
toll' Y 1090. Production and recovery of fusion proteins was obtained overlying nitrocellulose
filters impregnated with 10 mM isopropylthiogalactoside (Sigma Chemical Co., St. Louis,
MO). Immunopositive clones were detected by immunoblot technique using affinity-purified
human anti-50-kD antibodies at a dilution of 1 :25. All these clones were purified and used
to lysogenize Y1089 cells (9). To show that the fusion protein was responsible for the signal,
total extract proteins from E. coli Y1089, and from lysogenes obtained with immunopositive
clones, or nonrecombinant clones, with or without a-galactosidase induction were performed,
and analyzed by immunoblotting. Four clones called LKMC1, LKMC2, LMKC3, and
LKMC4 were further analyzed.
Analysis of Crossreactivity Between Fusion Proteins and the 50-kD Protein.
￿
The following proce-
dures were used: (a) Isolated immunopositive LKMCI clone was plated and fusion protein
was recovered following the technique used for the cDNA library. Filters were blocked and
incubated with affinity-purified human anti-50-kD antibodies at a dilution of 1 :25, at 4°C
overnight. After washing, bound antibodies were eluted by treatment of the filters with 50
mM glycine, pH 3, 3 min at room temperature, and the pH of the solution was immediately
neutralized with 1 M Tris, pH 8. Eluted antibodies were analyzed by immunoblotting against
total rat liver microsomal proteins. (b) Purified fusion protein prepared from clone LKMC4
as described (10), was injected to a rabbit according to standard procedures(11). Pre-immune
rabbit serum and serum after three injections were tested by immunoblot analysis on total
rat liver microsomal protein. (c) Purified fusion protein from clone LKMC4 was tested in
immunoblot against LKMA positive total human sera.
Immunoblot Analysis.
￿
SDS-polyacrylamide gels of 10% were used for the electrophoresis
of total rat liver microsomal proteins and of 7 .5% in the case of total extracts or purified
fusion protein. 5 wg of p-galactosidase were loaded as an M, marker. Electroblotting onto
nitrocellulose and different steps of the immunoblot procedure were essentially done as de-
scribed by Towbin et al. (12). Normal human serum (control), affinity-purified human anti-
50-kD antibodies and LKMA-positive human sera were used for immunoblot analysis at a
dilution between 1 :25 and 1 :1,000. Second antibodies, goat anti-human and anti-rabbit IgG,
labeled with horseradish peroxidase (Byosis, Compiegne, France), were used at 1 :1,000 dilu-
tion. Immunoblots were developed for 1 min with diaminobenzidine in 50 mM Tris-HC1,
pH 7.5 (0 .5 mg/ml), and H202 (final concentration of 0.01%).
Restriction Mapping and Sequencing of cDNA of Immunopositioe Clones.
￿
cDNA from clones
LKMC1, LKMC2, LKMC3, and LKMC4 were prepared and subcloned in the Eco RI site
of the vector pGEM2 (Promega Biotec, Madison, WI). A restriction map was obtained from
these clones with the following enzymes: ApaI, Aval, BamHI, Bg1I, Bg1II, HindII, HindIII,
Hpal, Ncol, and PstI (Boehringer Mannheim Biochemicals, Penzberg, Federal Republic of
Germany). The Hind III-Bam HI 608-bp fragment of LKMCl was subcloned in phages M13
mp10 and mpll and sequenced using the method of Sanger et al. (13).
Results and Discussion
Immunoscreening of the rat liver cDNA library in phage XGT11 with purified
human anti-50-kD antibodies allowed us to detect twelve independent immunopositive
clones from a total of 4 x 105 recombinant phages tested. Because of the known
crossreactivity of the LKMA with the native forms of various inducible P450s in
rat liver (4), fusion proteins were tested under denaturating conditions. Eight clones
gave a positive signal, and four of them (called LKMCl to LKMC4) were used
for further testing. Fig. 1 A, lane c shows the positive signal for LKMC4.
The crossreactivity between fusion proteins of two subclones (LKMC1 and
LKMC4) and the 50-kD endoplasmic reticulum protein was demonstrated by three
methods (Fig. 1): (a) Human antibodies eluted from nitrocellulose filters contain-
ing LKMC1 fusion protein also recognized a 50-kD protein on immunoblot of to-GUEGUEN ET AL .
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FIGURE 1.
￿
Analysis ofcrossreactivity between fusion proteins from clonesLKMC1 andLKMC4
and the 50-kD rat microsomal protein. (A) LKMC4-purified fusion protein wasanalyzed by im-
munoblot technique . (a) 5 ug of p-galactosidase . (b-d) 5 ug of purified LKMC4 protein (-150
kD) . Lanes aand b were stainedwith Ponceau red. Lanescanddwere revealed with affinity-purified
human anti-50-kD antibodies (1 :25 dilution) and LKMA-positive human serum (1 :1,000 dilu-
tion), respectively . (B) Rat liver total microsomal proteins were electroblotted on a nitrocellulose
paper and revealed using: (a)LKMA-positive serum (dilution 1 :1,000) ; (b) antibodies eluted from
nitrocellose filters, where LKMC1 fusion protein was previously bound (dilution 1 :25) ; and (c)
serum from a rabbit immunized against LKMC4-purified fusion protein (dilution 1 :1,000) .
tal rat liver microsomal proteins (Fig . 1 B, lane b) ; (b) serum from the rabbit
immunized againstLKMC4 fusion protein also recognized a 50-kD protein under
the same conditions (Fig. 1 B, lane c) ; (c) LKMA-positive human sera recognized
LKMC4-purified fusion protein on immunoblot (Fig . 1 A, lane d) .
The identification of cDNA inserts was done by restriction mapping . We com-
pared the restriction maps of LKMCI, LKMC2, LKMC3, and LKMC4 (Fig . 2)
with those from already sequenced rat P450s, because previous work had shown
that human LKMA recognizes methylcholantrene-inducible forms of rat liver
cytochrome P450 . With the enzymes used in this study, we found that the maps
of LKMC1 and LKMC2 were identical to that of the 5' region of P450 db2 from
the IID subfamily. We thus sequenced the 608-bp Hind III-Bam HI fragment of
LKMC1 and confirmed this identity since it showed complete homology with the
rat liver P450 db2 deduced amino acid sequence (14) . The restriction map ofcDNAs
from the clones LKMC3 and LKMC4 was identical to that of the 3' end of the
rat P450 dbl form, the other P450 isozyme described in the IID subfamily. Taken
together, these results demonstrate thatLKMA is directed against cytochromes P450
from the rat IID subfamily. The rat liver isozymes dbl and db2 have 78 and 7370
nucleotide and amino acid sequence homology, respectively. Therefore, it is not sur-
prising that LKMA recognizes both dbl and db2 forms . Clones corresponding to804
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FIGURE 2.
￿
Composition of re-
striction maps ofclones LKMCl,
LKMC2, LKMC3, and LKMC4,
an45and db(14). The
restriction maps ofclones LKMC1
and LKMC2 showed a complete
identity with P450 db2, 5' region.
LKMC3 and LKMC4 restriction
maps were identical to the 3' end
of P450 dbl.
i
P450 db2 (LKMC1 and LKMC2) and dbl (LKMC3 and LKMC4) overlap on a
region of high homology (ti90%) of 350 bp, allowing to speculate that the com-
mon epitope recognize by LKMA on immunoblots is located in that area coding
for 115 amino acids.
In human liver, the only P450 isozyme known to be expressed from the III) sub-
family is dbl (15). The human form has 71% amino acid homology with both db1
and db2 from rat liver (16). This suggests that in children with autoimmune chron-
ic hepatitis, LKMA is originally directed against the human P450 dbl form. In-
deed, immunoblot analysis of proteins from human liver microsomes shows that
LKMA recognizes a band ofelectrophoretical mobility higher than that of the rat
(4). The difference between human and rat antigens Mr is N2 kD and corresponds
to differences between published rat P450 dbl and db2 and human P450 dbl-deduced
amino acid sequences.
The production of very high titers of anti-P450 antibodies as a reaction of the
immune system against a protein liberated by cellular lysisis intriguing. Most prob-
ably another event, for example, a virus infection, could be the initial trigger of
the autoimmune process. Recently, several reports showed homologies between an-
tigens recognized by antibodies present in the course ofautoimmune disorders and
viral proteins (for review, see reference 17). Eventually, B lymphocytes can beboosted
by the P450 liberated by the cellular lysis. It was demonstrated in animals having
an autoimmune disease that a constant immunization is responsible for the devel-
opment and maintaining of high titers of autoimmune antibodies (18).
Summary
Children with autoimmune hepatitishave high serum titers ofantibodies directed
against a 50-kD protein ofrat liver endoplasmic reticulum. Affinity-purified anti-
50-kD antibodies were used to screen a rat liver cDNA library in XGT-11 expression
vector. 12 immunopositive clones were obtained. Crossreactivities between fusion
proteins ofthese clones and the 50-kD protein was demonstrated, and four clones
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were analyzed by restriction mapping, one of them by nucleotide sequencing. Com-
plete identity was found between the restriction maps of two clones (LKMC1 and
LKMC2) and that of the 5' end of the rat cytochrome P450 db2. Sequence of a 608-
bp fragment of LKMC1 showed complete homology with the rat P450 db2 form.
The restriction map of the other two clones (LKMC3 and LKMC4) was identical
to that of rat P450 dbl . These results suggest that the antigen recognized by LKMA
is a P450 of the IID subfamily.
We thank Dr. G. Kreibich for helpful discussions.
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